HomeProductsBioactive CompoundsAnti-Infective AgentsAntibacterial AgentsSparfloxacin
Chemical structure of CAS 110871-86-8

Sparfloxacin

In Stock•Starting at $113 for 25 g•Purity ≥ 99%
CAS No.110871-86-8
MDL No.MFCD00869619
MFC19H22F2N4O3
MW392.40
InChI KeyDZZWHBIBMUVIIW-DTORHVGOSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
25 g99+%$113In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Sparfloxacin is a fluoroquinolone antibiotic, a quinolone, a quinolinemonocarboxylic acid, and an N-arylpiperazine.

CAS No.110871-86-8
Product NameSparfloxacin

Associated Conditions

bacterial disease·osteomyelitis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.

Antimicrobial agents and chemotherapy • Vol. 44, Issue 2 • 2000
PMID: 10639351PMC: PMC89672DOI: 10.1128/AAC.44.2.283-286.2000

Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.

The Journal of antimicrobial chemotherapy • Vol. 45, Issue 5 • 2000
PMID: 10797078DOI: 10.1093/jac/45.5.583

Possible relationship between phototoxicity and photodegradation of sitafloxacin, a quinolone antibacterial agent, in the auricular skin of albino mice.

Toxicological sciences : an official journal of the Society of Toxicology • Vol. 56, Issue 2 • 2000
PMID: 10910986DOI: 10.1093/toxsci/56.2.290

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy • Vol. 44, Issue 9 • 2000
PMID: 10952625PMC: PMC90115DOI: 10.1128/AAC.44.9.2581-2584.2000

Documentation

Similar Products